These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22569947)

  • 1. The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients.
    Feuer EJ; Lee M; Mariotto AB; Cronin KA; Scoppa S; Penson DF; Hachey M; Cynkin L; Carter GA; Campbell D; Percy-Laurry A; Zou Z; Schrag D; Hankey BF
    Cancer; 2012 Nov; 118(22):5652-62. PubMed ID: 22569947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.
    Feuer EJ; Rabin BA; Zou Z; Wang Z; Xiong X; Ellis JL; Steiner JF; Cynkin L; Nekhlyudov L; Bayliss E; Hankey BF
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):265-74. PubMed ID: 25417240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
    Abdollah F; Sun M; Schmitges J; Tian Z; Jeldres C; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Eur Urol; 2011 Nov; 60(5):920-30. PubMed ID: 21741762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
    Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
    J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
    Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
    J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.
    Yang L; Shen W; Sakamoto N
    J Clin Oncol; 2013 Feb; 31(4):468-74. PubMed ID: 23270002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.
    Eloranta S; Adolfsson J; Lambert PC; Stattin P; Akre O; Andersson TM; Dickman PW
    Cancer Causes Control; 2013 Mar; 24(3):505-15. PubMed ID: 23296456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
    Howlader N; Mariotto AB; Woloshin S; Schwartz LM
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):255-64. PubMed ID: 25417239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a prognostic nomogram for identifying those factors which influence the 2- and 5-year survival chances of Taiwanese women diagnosed with breast cancer.
    Fan YP; Liu CL; Chiang IJ; Lin CY
    Eur J Cancer Care (Engl); 2011 Sep; 20(5):620-6. PubMed ID: 21410802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating life expectancy and related probabilities in screen-detected breast cancer patients with restricted follow-up information.
    Straatman H; Verbeek AL; Peer PG; Borm G
    Stat Med; 2004 Feb; 23(3):431-48. PubMed ID: 14748037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
    Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ
    Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a prognostic nomogram for terminally ill cancer patients.
    Feliu J; Jiménez-Gordo AM; Madero R; Rodríguez-Aizcorbe JR; Espinosa E; Castro J; Acedo JD; Martínez B; Alonso-Babarro A; Molina R; Cámara JC; García-Paredes ML; González-Barón M
    J Natl Cancer Inst; 2011 Nov; 103(21):1613-20. PubMed ID: 21972226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of mycosis fungoides in patients in the Southeast of England.
    Morales MM; Putcha V; Evans HS; Olsen J; Llopis A; Møller H
    Dermatology; 2005; 211(4):325-9. PubMed ID: 16286740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-care utilization by prognosis profile in a managed care setting: using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC.
    Rabin BA; Ellis JL; Steiner JF; Nekhlyudov L; Feuer EJ; Hankey BF; Cynkin L; Bayliss E
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):275-81. PubMed ID: 25417241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a Web-based prognostic system for breast cancer.
    Lundin J; Lundin M; Isola J; Joensuu H
    Stud Health Technol Inform; 2004; 107(Pt 1):237-40. PubMed ID: 15360810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.